About: Esreboxetine

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Esreboxetine (developmental code names AXS-14, PNU-165442G) is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued. It is the (S,S)-(+)-enantiomer of reboxetine and is even more selective as a norepinephrine reuptake inhibitor in comparison. However, recently it has been found that esreboxetine could be effective in fibromyalgia patients.

Property Value
dbo:abstract
  • Esreboxetine (developmental code names AXS-14, PNU-165442G) is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued. It is the (S,S)-(+)-enantiomer of reboxetine and is even more selective as a norepinephrine reuptake inhibitor in comparison. However, recently it has been found that esreboxetine could be effective in fibromyalgia patients. (en)
dbo:casNumber
  • 98819-76-2
dbo:fdaUniiCode
  • L8S50ZY490
dbo:kegg
  • D09340
dbo:pubchem
  • 65856
dbo:thumbnail
dbo:wikiPageID
  • 26476724 (xsd:integer)
dbo:wikiPageLength
  • 4423 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1082990610 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • None (en)
dbp:c
  • 19 (xsd:integer)
dbp:casNumber
  • 98819 (xsd:integer)
dbp:chemspiderid
  • 59268 (xsd:integer)
dbp:h
  • 23 (xsd:integer)
dbp:iupacName
  • -2 (xsd:integer)
  • methyl]morpholine (en)
dbp:iupharLigand
  • 4808 (xsd:integer)
dbp:kegg
  • D09340 (en)
dbp:legalStatus
  • Uncontrolled (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 3 (xsd:integer)
dbp:pubchem
  • 65856 (xsd:integer)
dbp:routesOfAdministration
dbp:smiles
  • CCOC1=CC=CC=C1O[C@H]C3=CC=CC=C3 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • CBQGYUDMJHNJBX-OALUTQOASA-N (en)
dbp:synonyms
  • AXS-14; PNU-165442G (en)
dbp:unii
  • L8S50ZY490 (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 451553392 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:width
  • 150 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Esreboxetine (developmental code names AXS-14, PNU-165442G) is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued. It is the (S,S)-(+)-enantiomer of reboxetine and is even more selective as a norepinephrine reuptake inhibitor in comparison. However, recently it has been found that esreboxetine could be effective in fibromyalgia patients. (en)
rdfs:label
  • Esreboxetine (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License